The Scientist

» drug development

Most Recent

image: Next Generation: Cancer Drug in Disguise

Next Generation: Cancer Drug in Disguise

By | November 5, 2013

Researchers develop a strategy for rendering a toxic drug harmless—until it encounters a pair of enzymes that signals cancer cells are nearby.

2 Comments

image: Capsule Reviews

Capsule Reviews

By | November 1, 2013

Tracks and Shadows, The Gap, The Cure in the Code, and An Appetite for Wonder

0 Comments

image: Speaking of Science

Speaking of Science

By | November 1, 2013

November 2013's selection of notable quotes

2 Comments

image: Penetrating the Brain

Penetrating the Brain

By | November 1, 2013

Researchers use molecular keys, chisels, and crowbars to open the last great biochemical barricade in the body—the blood-brain barrier.

3 Comments

image: Company Size Won’t Predict Success

Company Size Won’t Predict Success

By | October 23, 2013

New analysis finds that the size of a company is not tied to getting a drug to market.

0 Comments

image: A New Antibiotic?

A New Antibiotic?

By | October 16, 2013

Scientists show that peptide-conjugated phosphorodiamidate morpholino oligomers can effectively silence essential bacterial genes.

4 Comments

image: Centipede Venom Tops Morphine

Centipede Venom Tops Morphine

By | October 1, 2013

The substance targets the same ion channel that's mutated in people who don't feel pain.

0 Comments

image: Speaking of Science

Speaking of Science

By | October 1, 2013

October 2013's selection of notable quotes

0 Comments

image: Opinion: Reasons for the R&D Crisis

Opinion: Reasons for the R&D Crisis

By | September 23, 2013

Response to an opinion in The Scientist charting current pitfalls in translational research

2 Comments

image: Opinion: Sexual Dysfunction Matters

Opinion: Sexual Dysfunction Matters

By | August 19, 2013

Desire and arousal disorders require the biopharmaceutical industry’s attention.

7 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. Genetic Analysis Reveals the Evolutionary History of Dogs
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS